HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model.

AbstractBACKGROUND:
Dendritic cells are the most powerful of the antigen-presenting cells and are known to play important roles in sensitization and inflammation in allergen-specific asthma. Various cytokines and chemokines are involved in the maturation and activation of dendritic cells. Among them is CC chemokine ligand (CCL)21, a key chemokine in the entry of naive T cells and antigen-stimulated dendritic cells into the T-cell zones of secondary lymphoid organs, which is a critical process in antigen-specific T-cell activation.
OBJECTIVE:
We studied the role of CCL21 in airway inflammation in asthma by using BALB/c-plt/plt (plt) mice, which possess genetic defects in expression of both CCL21 and CCL19.
METHODS:
Plt and control BALB/c mice were immunized with ovalbumin and alum 4 times and thereafter were subjected to a 2-week regimen of ovalbumin inhalation.
RESULTS:
In plt mice, ovalbumin-specific IgE response was delayed compared with control BALB/c mice, but they had the same level of response after final immunization. Although airway inflammation and response to acetylcholine were significantly reduced compared with BALB/c mice, significant eosinophilic inflammation and hyperresponsiveness were also observed in plt mice after 2 weeks of inhalation. Four weeks after cessation of inhalation, airway inflammation and hyperresponsiveness in plt mice were greater than in BALB/c mice. At the time of resolution of airway inflammation, IL-10 production was enhanced in BALB/c mice but not in plt mice.
CONCLUSION:
The chemokines CCL21 and CCL19 were critical for resolution of airway inflammation.
CLINICAL IMPLICATIONS:
The findings about the chemokines for induction and resolution of inflammation are key to establishing a new strategy for asthma immunotherapy.
AuthorsNaomi Yamashita, Hiroyuki Tashimo, Yukiko Matsuo, Hirofumi Ishida, Kenta Yoshiura, Katsuaki Sato, Naohide Yamashita, Terutaka Kakiuchi, Ken Ohta
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 117 Issue 5 Pg. 1040-6 (May 2006) ISSN: 0091-6749 [Print] United States
PMID16675330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCL19 protein, human
  • CCL21 protein, human
  • CCR7 protein, human
  • Ccl19 protein, mouse
  • Ccl21c protein, mouse
  • Ccr7 protein, mouse
  • Chemokine CCL19
  • Chemokine CCL21
  • Chemokines, CC
  • Epitopes, T-Lymphocyte
  • Immunoglobulin G
  • Inflammation Mediators
  • Receptors, CCR7
  • Receptors, Chemokine
  • Receptors, Interleukin-2
  • Immunoglobulin E
  • Ovalbumin
Topics
  • Animals
  • Asthma (genetics, immunology, metabolism)
  • Bronchial Hyperreactivity (immunology, pathology)
  • Chemokine CCL19
  • Chemokine CCL21
  • Chemokines, CC (deficiency, genetics, physiology)
  • Disease Models, Animal
  • Epitopes, T-Lymphocyte (genetics, immunology)
  • Humans
  • Hypersensitivity (genetics, immunology, pathology)
  • Immunoglobulin E (biosynthesis)
  • Immunoglobulin G (biosynthesis)
  • Inflammation (immunology, metabolism, pathology)
  • Inflammation Mediators (administration & dosage, physiology)
  • Lymph Nodes (abnormalities, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Mutant Strains
  • Ovalbumin (immunology)
  • Receptors, CCR7
  • Receptors, Chemokine (biosynthesis, genetics)
  • Receptors, Interleukin-2 (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: